195 related articles for article (PubMed ID: 37258039)
21. Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute-on-chronic liver failure development and prognosis in patients with liver cirrhosis.
Enomoto M; Takaya H; Namisaki T; Fujinaga Y; Nishimura N; Sawada Y; Kaji K; Kawaratani H; Moriya K; Akahane T; Inoue T; Matsumoto M; Yoshiji H
Hepatol Res; 2022 Apr; 52(4):390-400. PubMed ID: 34964539
[TBL] [Abstract][Full Text] [Related]
22. Association between ADAMTS13 activity-VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma.
Takaya H; Namisaki T; Moriya K; Shimozato N; Kaji K; Ogawa H; Ishida K; Tsuji Y; Kaya D; Takagi H; Fujinaga Y; Nishimura N; Sawada Y; Kawaratani H; Akahane T; Matsumoto M; Yoshiji H
World J Gastroenterol; 2020 Dec; 26(45):7232-7241. PubMed ID: 33362379
[TBL] [Abstract][Full Text] [Related]
23. Involvement of the ADAMTS13-VWF axis in acute Kawasaki disease and effects of intravenous immunoglobulin.
Tsujii N; Nogami K; Matsumoto M; Yoshizawa H; Takase T; Tanaka I; Sakai T; Fukuda K; Hayakawa M; Sakai K; Isonishi A; Matsuura K; Fujimura Y; Shima M
Thromb Res; 2019 Jul; 179():1-10. PubMed ID: 31055186
[TBL] [Abstract][Full Text] [Related]
24. Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.
Hauschild A; Larkin J; Ribas A; Dréno B; Flaherty KT; Ascierto PA; Lewis KD; McKenna E; Zhu Q; Mun Y; McArthur GA
JAMA Oncol; 2018 Oct; 4(10):1382-1388. PubMed ID: 30073321
[TBL] [Abstract][Full Text] [Related]
25. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
Liu L; Ling J; Ma Z; Yuan Q; Pan J; Yang H
Mol Med Rep; 2015 Apr; 11(4):3015-20. PubMed ID: 25482054
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
[TBL] [Abstract][Full Text] [Related]
27. Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population.
Wang Z; Dou M; Du X; Ma L; Sun P; Cao H; Ye S; Jiang P; Liu F; Lin F; Zhang R; Li C
PeerJ; 2017; 5():e3156. PubMed ID: 28382235
[TBL] [Abstract][Full Text] [Related]
28. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
Matsuyama T; Uemura M; Ishikawa M; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Takimura C; Fujimura Y; Fukui H
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S27-35. PubMed ID: 17331163
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma.
Waninger JJ; Fecher LA; Lao C; Yentz S; Green MD; Demirci H
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497270
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of the ADAMTS13-vWF axis in disseminated intravascular coagulation: Platelet count/vWF:Ag ratio as a strong prognostic marker.
Jang J; Gu J; Kim HK
Int J Lab Hematol; 2022 Jun; 44(3):595-602. PubMed ID: 34939330
[TBL] [Abstract][Full Text] [Related]
31. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance.
Philippe A; Gendron N; Bory O; Beauvais A; Mirault T; Planquette B; Sanchez O; Diehl JL; Chocron R; Smadja DM
Angiogenesis; 2021 Aug; 24(3):407-411. PubMed ID: 33974165
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
Heppt MV; Heinzerling L; Kähler KC; Forschner A; Kirchberger MC; Loquai C; Meissner M; Meier F; Terheyden P; Schell B; Herbst R; Göppner D; Kiecker F; Rafei-Shamsabadi D; Haferkamp S; Huber MA; Utikal J; Ziemer M; Bumeder I; Pfeiffer C; Schäd SG; Schmid-Tannwald C; Tietze JK; Eigentler TK; Berking C
Eur J Cancer; 2017 Sep; 82():56-65. PubMed ID: 28648699
[TBL] [Abstract][Full Text] [Related]
33. Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Brown JT; Liu Y; Shabto JM; Martini D; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni L; Joshi SS; Kissick H; Ogan K; Nazha B; Carthon BC; Kucuk O; Harris WB; Master VA; Bilen MA
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34326170
[TBL] [Abstract][Full Text] [Related]
34. The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer.
Colonne CK; Favaloro EJ; Pasalic L
Healthcare (Basel); 2022 Mar; 10(3):. PubMed ID: 35327035
[TBL] [Abstract][Full Text] [Related]
35. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
Reiter RA; Knöbl P; Varadi K; Turecek PL
Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
[TBL] [Abstract][Full Text] [Related]
36. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of total metabolic tumour volume and therapy-response assessment by [
Annovazzi A; Ferraresi V; Rea S; Russillo M; Renna D; Carpano S; Sciuto R
Eur Radiol; 2022 May; 32(5):3398-3407. PubMed ID: 34779873
[TBL] [Abstract][Full Text] [Related]
38. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
39. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates.
Strauss T; Elisha N; Ravid B; Rosenberg N; Lubetsky A; Levy-Mendelovich S; Morag I; Nowak Göttl U; Kenet G
Blood Cells Mol Dis; 2017 Sep; 67():14-17. PubMed ID: 28087247
[TBL] [Abstract][Full Text] [Related]
40. Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations.
Ascierto PA; Capone M; Grimaldi AM; Mallardo D; Simeone E; Madonna G; Roder H; Meyer K; Asmellash S; Oliveira C; Roder J; Grigorieva J
J Immunother Cancer; 2019 Mar; 7(1):91. PubMed ID: 30925943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
